Neutrogena Dermatologics, a unit of Neutrogena, has introduced skin iD, a personalized acne solution clinically proven to treat and prevent acne. In a clinical trial of 500 people with different skin, acne and lifestyles, 100% of people using skin iD got clearer, healthier-looking skin, according to the company.
Skin iD is currently the only non-prescription acne solution on the market that has conducted a double blind, randomized, placebo-controlled clinical trial, according to Neutrogena. This clinical trial demonstrated skin iD’s power to work significantly better than the top-selling acne regimen in treating 16 different signs of acne.
In addition to product, the skin iD program includes a skin evaluation and a comprehensive website to treat each individual’s acne needs. It is available exclusively on skiniD.com, and showcased through a series of infomercials starring “American Idol” singer Katharine McPhee.
“We wanted to create a highly effective acne solution to meet the needs of individuals who are not satisfied with their existing acne regimen,” said Jim Colleran, president, Neutrogena Corporation. “Skin iD was developed with an innovative one-on-one approach. We determined that offering consumers access to skin iD through a dedicated website or by phone would allow for the dialogue necessary to evaluate their unique skin care needs and provide a personalized regimen.” More info: www.skinid.com